Network·Venture Capital
Late-stage venture capital and growth equity firm specializing in medical devices, in vitro diagnostics, and disruptive digital health. Focuses on private companies with commercialized products that need growth capital to achieve profitability.
This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Check Size
$10.0B–$10.0B
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.